Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Reversal of pipecuronium-induced neuromuscular blockade with Sugammadex during sevoflurane anesthesia
2025-521375-31-00Phase 4Authorised
- Sponsor
- University of Debrecen
- Start
- Jun 2025
- Modality
- Small Molecules, Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 4, randomised trial of Sugammadex, sponsored by University of Debrecen. Planned start Jun 2025; status: authorised.
02
Drugs
Sugammadex
Beyond the preview
Go deeper on 2025-521375-31-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2025-521375-31-00.